Treatment with either conventional CAR70-T cells or AlloCAR70-NKT cells suppressed tumor growth and prolonged mouse survival in the CD70-expressing model of PDX#22 and 786-O-FG, with AlloCAR70-NKT cells demonstrating superior antitumor efficacy (Figures 5B–5D and 5F–5H). Here, CD70 is linked to neoplasm.